While eating a nutritious diet, losing weight, and becoming more physically active are widely recognized strategies that can significantly reduce the risk of type 2 diabetes, groundbreaking research reveals that these lifestyle changes do not offer the same level of protection to everyone, creating a critical exception for individuals assigned to Tübingen's type 2 diabetes risk cluster 5. The findings, published in the scientific journal Diabetes by scientists from the German Center for Diabetes Research (DZD), the University Hospital Tübingen, and Helmholtz Munich, stem from a detailed re-examination of the Tübingen Lifestyle Intervention Program (TULIP), a study that initially separated at-risk individuals into six distinct clusters based on their likelihood of developing diabetes and the progression of related complications. Although clusters 3 and 5 were already identified as having an especially high probability of developing the disease, the latest analysis sought to determine if long-term weight loss and lifestyle-based prevention could alter these outcomes across different risk groups. The researchers focused specifically on participants who achieved substantial weight loss and successfully maintained it over a nine-year monitoring period following a two-year lifestyle program, expecting to see universal improvements. However, the results were starkly different for cluster 5, where participants continued to experience rising blood sugar, a sharp decline in insulin production, and a consistently elevated risk of developing diabetes despite their efforts. Professor Norbert Stefan, the lead author of the study, highlighted the unexpected nature of these outcomes, explaining, "We were particularly interested in whether individuals in risk clusters 3 and 5 differed from those in other clusters with regard to improvements in blood glucose levels and the prevention of type 2 diabetes," and adding, "We were very surprised to find that, despite a large and sustained weight loss of 8% and after a very long follow-up period of 9 years, individuals in risk cluster 5 showed increasing blood glucose levels, declining insulin secretion, and a persistently high risk of type 2 diabetes." To understand why lifestyle intervention appeared to provide less protection for this specific group, the team investigated the underlying biological mechanisms, discovering that severe fatty liver disease likely played a major role by driving insulin resistance and impairing the ability of pancreatic beta cells to release insulin, which contributed to higher blood sugar levels regardless of the weight lost. These findings support earlier evidence suggesting that fatty liver disease and insulin resistance are the primary disease processes affecting people in cluster 5, characteristics that may leave them especially vulnerable to both type 2 diabetes and cardiovascular disease. The results indicate that people in cluster 5 may not receive the same metabolic benefits from standard lifestyle interventions as people in other risk groups, even when they achieve substantial and lasting weight loss, particularly when researchers examined blood sugar regulation. Consequently, the study suggests that if future prospective research confirms these findings, the approach to diabetes prevention may need to become more personalized, with individuals possessing high-risk biological profiles such as cluster 5 requiring more intensive care or treatments specifically designed to address their unique metabolic problems rather than relying solely on diet and exercise.